Cooled Versus Conventional Genicular Radiofrequency Ablation for Chronic Knee Pain
TerminatedNCT04275128
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This prospective observational study seeks to compare pain relief and disability following cooled radiofrequency ablation (Coolief) versus conventional genicular nerve ablation in patients with chronic knee pain. Patients' NRS for pain, WOMAC, and ODI score at baseline and 1, 3 and 6 months after treatment will be used to evaluate whether Coolief is more effective at reducing disability and improving pain relief.
Study details
- Official title
- Cooled Genicular Radiofrequency Ablation Versus Conventional Genicular Radiofrequency Ablation for the Treatment of Chronic Knee Pain: A Prospective Study
- Conditions
- Interventions
- Device: Cooled radiofrequency ablation
- Device: Conventional radiofrequency ablation
- Sponsor
- Henry Ford Health System
- Start date
- 2020-07-11
- Primary completion
- 2020-09-24
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult male or female (above age of 18) * Diagnosed with chronic knee osteoarthritis or post Total Knee Arthroscopy or post Total Knee Replacement Pain * More than 3 months of knee pain * Scheduled for Genicular Knee ablation (Cooled or conventional ablation) * Had previous intra articular injection (steroids or Hyaluronic acids) if not a post-surgical knee pain patient * Achieved minimum 50% relief from genicular block x 2 * Numeric Rating Scale Score of 4 or greater * Kellgren-Lawrence Knee Osteoarthritis Grade 2 or greater (in non post-surgical patients) Exclusion Criteria: * Pregnant adult female * Patient fully anticoagulated * Antiplatelet Use * History of Clotting Disorder * Refusal to participate * Focal neurologic deficits * Cognitive deficits * History of Bone Cancer * Mental Health Illness which causes instability * Previous Knee radiofrequency ablation * Active Infection * Allergy to Medications Administered
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04275128